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Abstract
Background: Type 2 diabetes (T2D) is the most common form of diabetes in humans and is closely associated
with dyslipidemia and obesity that magnifies the mortality and morbidity related to T2D. The genetic contribution
to human T2D and related metabolic disorders is evident, and mostly follows polygenic inheritance. The TALLYHO/
JngJ (TH) mice are a polygenic model for T2D characterized by obesity, hyperinsulinemia, impaired glucose uptake
and tolerance, hyperlipidemia, and hyperglycemia.
Results: In order to determine the genetic factors that contribute to these T2D related characteristics in TH mice,
we interbred TH mice with C57BL/6J (B6) mice. The parental, F1, and F2 mice were phenotyped at 8, 12, 16, 20,
and 24 weeks of age for 4-hour fasting plasma triglyceride, cholesterol, insulin, and glucose levels and body, fat
pad and carcass weights. The F2 mice were genotyped genome-wide and used for quantitative trait locus (QTL)
mapping. We also applied a genetical genomic approach using a subset of the F2 mice to seek candidate genes
underlying the QTLs. Major QTLs were detected on chromosomes (Chrs) 1, 11, 4, and 8 for hypertriglyceridemia, 1
and 3 for hypercholesterolemia, 4 for hyperglycemia, 11 and 1 for body weight, 1 for fat pad weight, and 11 and
14 for carcass weight. Most alleles, except for Chr 3 and 14 QTLs, increased phenotypic values when contributed
by the TH strain. Fourteen pairs of interacting loci were detected, none of which overlapped the major QTLs. The
QTL interval linked to hypercholesterolemia and hypertriglyceridemia on distal Chr 1 contains Apoa2 gene.
Sequencing analysis revealed polymorphisms of Apoa2 in TH mice, suggesting Apoa2 as the candidate gene for
the hyperlipidemia QTL. Gene expression analysis added novel information and aided in selection of candidates
underlying the QTLs.
Conclusions: We identified several genetic loci that affect the quantitative variations of plasma lipid and glucose
levels and obesity traits in a TH × B6 intercross. Polymorphisms in Apoa2 gene are suggested to be responsible for
the Chr 1 QTL linked to hypercholesterolemia and hypertriglyceridemia. Further, genetical genomic analysis led to
potential candidate genes for the QTLs.
Background
Diabetes is one of the most devastating and prevalent dis-
eases in humans. According to data from the 2007
National Diabetes Fact Sheet, 23.6 million people in the
United States (7.8% of the population) have diabetes http://
www.diabetes.org/diabetes-basics/diabetes-statistics/. Type
2 diabetes (T2D) is the most common form of diabetes and
is often associated with a collection of metabolic disorders
including dyslipidemia and obesity which substantially mag-
nifies the mortality and morbidity related to T2D [1,2].
Hypertriglyceridemia is the main lipid abnormality in T2D
patients that usually occurs years before diabetes, and is a
strong predictor of diabetes [2]. The genetic contribution to
human T2D and related metabolic disorders is evident, and
mostly follows polygenic inheritance [3,4].
TALLYHO/JngJ (TH) mice are a polygenic model for
T2D characterized by glucose intolerance and hyperglyce-
mia (limited to males) and show metabolic abnormalities
including obesity, insulin resistance, hyperinsulinemia, and
hyperlipidemia [5-7]. The TH male mice exhibit a striking
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any medium, provided the original work is properly cited.rise in plasma triglyceride levels at an early age when their
plasma glucose levels are steadily rising [6]. On the other
hand, TH female mice do not exhibit this triglyceride
spike although they maintain hypertriglyceridemia com-
pared with age- and sex-matched C57BL/6J (B6) mice.
Some degree of vascular dysfunction is also reported in
TH mice [8,9].
In the present study, we performed a genome-wide
scan to search for quantitative trait loci (QTLs) affecting
hypertriglyceridemia in TH mice using male F2 mice
from a cross of B6 × TH. We also searched for loci
linked to hypercholesterolemia, hyperinsulinemia, obe-
sity, and hyperglycemia. Finally, we applied a genetical
genomic approach and assessed the data systemically for
candidate genes at the QTLs.
Results
Phenotypes in parental, F1, and F2 mice
Body weights and 4-hour fasting plasma levels of trigly-
ceride, total cholesterol, insulin, and glucose were mea-
sured at 8, 12, 16, 20, and 24 weeks of age. At 24 weeks
of age, mice were killed and the five regional fat pads
were dissected and weighed. In the F2 intercross mice,
where B6 and TH genomes are mixed and reassembled,
there was wide variation in trait values that even
exceeded the ranges in parental mice (Table 1). This indi-
cates that multiple genetic variants between the parental
strains were responsible for the expression of traits.
Hypertriglyceridemia appeared to be inherited in a
semidominant manner since the mean plasma level of
triglyceride of F1 (B6 × TH) progeny was intermediate
between the means of the two parental strains (Table 1).
Hypercholesterolemia, on the other hand, showed a
complex inheritance.
The F1 population showed a mean plasma glucose
level that was indistinguishable from B6 strain, suggest-
ing that hyperglycemia is inherited in a recessive man-
ner for the TH alleles (Table 1). Plasma insulin levels in
F1 mice were between the parental values at 8 weeks of
age, but became similar to TH mice at later ages.
The F1 mice initially showed higher body weights than
B6 mice, but comparable to TH mice (Table 1). However,
at later ages hybrid vigor (or heterosis), where a first-
generation hybrid displays superior phenotypic expres-
sion over their parents, was observed for body weights.
Increases both in fat mass (measured by fat pad weights)
and lean mass (measured by carcass weight) appeared to
contribute to the increased body weights in the F1 mice.
Significant QTLs identified by composite interval
genome-wide scans
We collected approximately 380 F2 male mice, and indivi-
dual mice were genotyped with 68 simple sequence length
polymorphism (SSLP) markers at approximately 20-cM
intervals. A genome-wide QTL analysis was then per-
formed for the traits in the male F2 population at 8, 12,
16, 20, and 24 weeks of age. Figure 1 represents the distri-
bution of trait values at 24 weeks of age, with most traits
showing approximately normal distributions, but a few
traits had positive skew. Similar distribution patterns were
observed at all other ages for each trait (not shown). QTLs
with genome-wide significance levels > 5% are summar-
ized in Table 2. Lod score plots of genome-wide scans are
depicted in Figure 2 and 3 for traits with significant QTL.
Triglyceride
Four significant QTLs for plasma triglyceride level had
age-specific activity; loci near D1Mit113 on chromo-
some (Chr) 1 for 8 week, D11Mit132 on Chr 11 for 12
week, D4Mit178 o nC h r4f o r2 0w e e k ,a n dD8Mit242
on Chr 8 for 24 week. Hypertriglyceridemic contribu-
tions were from TH genome. TH alleles for Chr 1 and
Chr 4 QTLs appeared to be recessive while Chr 11 and
Chr 8 QTLs were dominant.
Cholesterol
A very significant QTL near D1Mit113 on Chr 1 was
linked to plasma total cholesterol levels. The hypercholes-
terolemic contribution of the locus was from the TH gen-
ome and appeared to be additive for all ages. In addition, a
QTL near D3Mit304 on proximal Chr 3 was also responsi-
ble for the plasma total cholesterol levels at 12 week; the
B6 allele at this locus was associated with increased plasma
levels in total cholesterol, appearing recessive.
Glucose
On distal Chr 4, a QTL near D4Mit312 was very signifi-
cantly linked to the plasma glucose levels, with 2 LOD
support interval (CI) of 66.3 - 70.3 cM. For that locus,
the TH alleles were associated with increased plasma
glucose levels, and inheritance appeared to be dominant
for the TH allele.
Insulin
No significant linkages were observed for plasma insulin
levels.
Body weight
Two significant QTLs linked to body weight were iden-
tified near D11Mit41 on Chr 11 and D1Mit215 on Chr
1. For both QTLs, the TH alleles contributed to
increased body weights with dominant action.
Fat pad weight
A significant QTL linked to fat pad weights was identi-
fied near D1Mit215 on Chr 1. The TH allele was asso-
ciated with increases in all regional fat pad weights
studied and appeared dominant for all except epididy-
mal fat pad weights.
Carcass weight
Two QTLs near D11Mit41 on Chr 11 and D14Mit107
on Chr 14, respectively, were significantly linked to car-
cass weights (surrogate lean body mass). The TH alleles
and the B6 alleles were associated with higher carcass
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The Chr 11 QTL location overlapped the QTL asso-
ciated with body weight.
Epistasis and interacting QTLs
A pair-wise genome scan was conducted to examine all
marker-marker interactions and identified 14 significant
epistatic interacting QTLs; 4 for triglyceride, 5 for total
cholesterol, 3 for glucose, and 2 for fat pad weight
(Table 3). When we compared these epistatic QTLs
with the single QTLs identified by single-locus genome
scans, no locations overlapped.
It was noteworthy that a locus near D19Mit30 on Chr
19 interacted with two different loci affecting plasma
glucose levels, one near D15Mit2 on Chr 15 and the
other near D12Mit233 on Chr 12. At 12 weeks of age,
Table 1 Phenotypes of the parental, F1, and F2 mice (males)
B6 (n) F1 (n) TH (n) F2 (n)
(lowest, highest)
16 F2 mice chosen for microarray
Lower (n = 8); Upper (n = 8)
Triglyceride (mg/dl)
8 wk 63 ± 12 (9)
a 153 ± 12 (15)
b 438 ± 41 (7)
c 168 ± 3 (368) (60, 472) 130 ± 14; 207 ± 22 (P = 0.009)
12 wk 68 ± 8 (14)
a 186 ± 11 (19)
b 237 ± 53 (9)
b 166 ± 3 (382) (44, 357) 135 ± 14; 230 ± 22 (P = 0.003)
16 wk 63 ± 3 (18)
a 168 ± 8 (19)
b 438 ± 39 (16)
c 167 ± 4 (384) (20, 486) 120 ± 15; 191 ± 27 (P = 0.038)
20 wk 71 ± 7 (18)
a 180 ± 20 (19)
b 367 ± 32 (16)
c 181 ± 4 (377) (56, 479) 126 ± 17; 336 ± 24 (P < 0.0001)
24 wk 60 ± 6 (18)
a 221 ± 19 (19)
b 368 ± 33 (16)
c 181 ± 4 (375) (40, 436) 81 ± 7; 331 ± 17 (P < 0.0001)
Cholesterol (mmol/l)
8 wk 2.9 ± 0.2 (9)
a 2.3 ± 0.1 (15)
b 4.0 ± 0.1 (7)
c 2.9 ± 0.1 (365) (0.7, 7.6) 2.2 ± 0.2; 2.9 ± 0.4 (P = 0.09)
12 wk 2.6 ± 0.2 (14)
a 3.1 ± 0.2 (19)
b 2.9 ± 0.1 (9)
b 3.1 ± 0.1 (378) (0.4, 8.5) 2.5 ± 0.3; 3.1 ± 0.5 (P = 0.36)
16 wk 3.0 ± 0.3 (19)
a 2.6 ± 0.1 (19)
a 3.6 ± 0.3 (16)
b 3.0 ± 0.1 (384) (1.0, 6.8) 2.5 ± 0.3; 3.6 ± 0.4 (P = 0.04)
20 wk 2.1 ± 0.1 (18)
a 3.5 ± 0.3 (19)
b 4.7 ± 0.3 (16)
c 3.3 ± 0.1 (377) (1.1, 6.8) 2.7 ± 0.3; 3.6 ± 0.2 (P = 0.03)
24 wk 1.9 ± 0.1 (18)
a 3.6 ± 0.1 (19)
b 4.0 ± 0.4 (16)
b 3.3 ± 0.1 (375) (1.3, 8.1) 2.8 ± 0.2; 3.1 ± 0.5 (P = 0.58)
Glucose (mg/dl)
8 wk 175 ± 10 (9)
a 175 ± 11 (15)
a 292 ± 48 (7)
b 176 ± 2 (368) (98, 353) 163 ± 11; 183 ± 9 (P = 0.20)
12 wk 132 ± 6 (14)
a 147 ± 9 (19)
a 252 ± 40 (9)
b 166 ± 2 (382) (45, 473) 145 ± 8; 168 ± 11 (P = 0.10)
16 wk 181 ± 14 (19)
a 166 ± 4 (19)
a 460 ± 38 (16)
b 169 ± 3 (384) (62, 575) 144 ± 15; 160 ± 11 (P = 0.40)
20 wk 177 ± 10 (18)
a 156 ± 5 (19)
a 364 ± 36 (16)
b 165 ± 3 (378) (64, 492) 144 ± 17; 163 ± 13 (P = 0.40)
24 wk 175 ± 10 (18)
a 162 ± 8 (19)
a 387 ± 33 (16)
b 162 ± 3 (375) (40, 599) 131 ± 9; 128 ± 13 (P = 0.83)
Insulin (ng/ml)
8 wk 0.07 ± 0.02 (9)
a 0.96 ± 0.17 (15)
b 1.81 ± 0.41 (7)
c 1.31 ± 0.06 (384) (0.01, 9.71) 1.45 ± 0.31; 1.36 ± 0.28 (P = 0.83)
12 wk 0.22 ± 0.07 (13)
a 1.12 ± 0.15 (19)
b 0.98 ± 0.33 (9)
b 1.55 ± 0.08 (376) (0.06, 12.36) 0.80 ± 0.14; 1.28 ± 0.17 (P = 0.05)
16 wk 0.35 ± 0.09 (18)
a 1.24 ± 0.13 (19)
b 0.98 ± 0.26 (15)
b 2.17 ± 0.11 (381) (0.07, 15.03) 1.19 ± 0.23; 1.94 ± 0.43 (P = 0.20)
20 wk 0.42 ± 0.11 (18)
a 2.14 ± 0.26 (19)
b 1.56 ± 0.41 (16)
b 2.39 ± 0.15 (376) (0.02, 23.18) 1.12 ± 0.36; 2.35 ± 0.47 (P = 0.06)
24 wk 0.41 ± 0.10 (10)
a 2.78 ± 0.55 (16)
b 2.31 ± 0.56 (13)
b 2.70 ± 0.16 (371) (0.06, 23.97) 2.59 ± 1.10; 5.13 ± 2.10 (P = 0.30)
Body weight (g)
8 wk 22 ± 0.4 (14)
a 30 ± 0.5 (15)
b 31 ± 0.5 (7)
b 29 ± 0.2 (385) (20, 40) 30 ± 1.1; 29 ± 0.9 (P = 0.33)
12 wk 24 ± 0.5 (18)
a 33 ± 0.6 (19)
b 32 ± 0.6 (16)
b 33 ± 0.2 (385) (23, 45) 33 ± 1.2; 33 ± 1.2 (P = 0.65)
16 wk 25 ± 0.5 (18)
a 36 ± 0.7 (19)
b 34 ± 0.8 (16)
b 35 ± 0.2 (383) (24, 49) 35 ± 1.5; 36 ± 1.3 (P = 0.66)
20 wk 27 ± 0.5 (18)
a 38 ± 0.7 (19)
b 36 ± 1.0 (16)
c 37 ± 0.3 (378) (25, 52) 36 ± 2.0; 38 ± 1.1 (P = 0.39)
24 wk 28 ± 0.4 (18)
a 41 ± 0.6 (19)
b 36 ± 1.4 (16)
c 39 ± 0.3 (373) (25, 59) 38 ± 2.2; 41 ± 1.3 (P = 0.26)
Fat pad & Carcass weights (g)
IG 0.34 ± 0.02 (18)
a 1.37 ± 0.07 (19)
b 0.69 ± 0.15 (16)
c 0.99 ± 0.03 (372) (0.07, 2.66) 0.64 ± 0.14; 1.14 ± 0.10 (P = 0.01)
ED 0.43 ± 0.03 (18)
a 1.86 ± 0.07 (19)
b 0.98 ± 0.23 (16)
c 1.41 ± 0.03 (372) (0.19, 3.21) 1.11 ± 0.25; 1.69 ± 0.19 (P = 0.08)
MS 0.11 ± 0.01 (18)
a 0.60 ± 0.03 (19)
b 0.24 ± 0.06 (16)
c 0.40 ± 0.01 (372) (0.07, 1.30) 0.35 ± 0.12; 0.46 ± 0.04 (P = 0.40)
RP 0.12 ± 0.01 (18)
a 0.64 ± 0.02 (19)
b 0.26 ± 0.06 (16)
c 0.43 ± 0.01 (371) (0.05, 1.47) 0.31 ± 0.07; 0.63 ± 0.13 (P = 0.05)
SC 0.14 ± 0.01 (18)
a 0.72 ± 0.04 (19)
b 0.32 ± 0.09 (16)
c 0.50 ± 0.02 (372) (0.05, 3.26) 0.32 ± 0.08; 0.59 ± 0.06 (P = 0.01)
Sum 1.14 ± 0.06 (18)
a 5.17 ± 0.20 (19)
b 2.34 ± 0.55 (16)
c 3.72 ± 0.09 (371) (0.52, 8.59) 2.69 ± 0.61; 4.51 ± 0.31 (P = 0.02)
Carcass 26 ± 0.4 (18)
a 34 ± 0.5 (19)
b 31 ± 1.0 (16)
c 33 ± 0.2 (371) (23, 47) 34 ± 1.8; 34 ± 1.0 (P = 0.91)
Data are presented as mean ± sem. Means labeled with different letters are significantly different from one another comparing B6, F1 and TH (P < 0.05). wk,
week; IG, inguinal; ED, epididymal; MS, mesenteric; RP, retroperitoneal including perirenal; SC, subscapular; Sum, sum of the 5 fat pads above; B6, C57BL/6J; TH,
TALLYHO/JngJ.
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Page 3 of 17Figure 1 Histogram showing distribution of traits at 24 weeks of age in F2 mice. We interbred TH mice with B6 mice, and the resultant F2
mice (male) were phenotyped at 8, 12, 16, 20, and 24 weeks of age for 4-hour fasting plasma triglyceride, total cholesterol, insulin, and glucose
levels and body, fat pad and carcass weights. Count is the number of mice.
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Page 4 of 17Table 2 Summary of major QTLs detected in the F2 mice
Chr Best location,
cM (CI)
Closest marker
to peak LOD
Peak LOD GW Sig. % Phenotype value
B6/B6 (n) B6/TH (n) TH/TH (n)
Triglyceride (mg/dl)
8 wk 1 95.7
(25.7, 96.9)
D1Mit113 3.67 S 3.63 157 ± 7 (89)
a 164 ± 4 (201)
a 188 ± 6 (78)
b
12 wk 11 65
(20, 79)
D11Mit132 3.76 S 1.72 153 ± 5 (90)
a 169 ± 4 (182)
b 173 ± 6 (109)
b
20 wk 4 31.3
(21.3, 41.3)
D4Mit178 4.47 VS 4.82 161 ± 6 (92)
a 178 ± 5 (201)
a 210 ± 9 (83)
b
24 wk 8 55.75
(50, 55.7)
D8Mit242 3.94 S 4.29 159 ± 7 (97)
a 185 ± 5 (186)
b 199 ± 8 (91)
b
Cholesterol (mmol/l)
8 wk 1 86.7
(84.7, 87.7)
D1Mit113 11.83 VS 4.96 2.5 ± 0.1 (88)
a 2.9 ± 0.1 (200)
b 3.2 ± 0.1 (77)
c
12 wk 1 89.7
(86.7, 96.7)
D1Mit113 6.55 VS 6.76 2.6 ± 0.1 (88)
a 3.2 ± 0.1 (211)
b 3.5 ± 0.1 (79)
c
3 10.6
(5.6, 11.6)
D3Mit304 4.07 S 4.31 3.5 ± 0.1 (102)
a 3.0 ± 0.1 (177)
b 2.9 ± 0.1 (99)
b
16 wk 1 93.7
(86.7, 96.9)
D1Mit113 7.99 VS 8.62 2.6 ± 0.1 (92)
a 3.0 ± 0.1 (212)
b 3.5 ± 0.1 (80)
c
20 wk 1 92.7
(86.7, 96.9)
D1Mit113 9.83 VS 11.05 2.8 ± 0.1 (89)
a 3.2 ± 0.1 (209)
b 3.9 ± 0.1 (79)
c
Glucose (mg/dl)
24 wk 4 67.3
(66.3, 70.3)
D4Mit312 6.13 VS 2.89 147 ± 4 (102)
a 167 ± 4 (205)
b 172 ± 8 (66)
b
Body weight (g)
20 wk 11 41
(32, 43)
D11Mit41 4.51 VS 2.17 36 ± 0.5 (72)
a 38 ± 0.4 (199)
b 38 ± 0.5 (103)
b
24 wk 11 41
(32, 43)
D11Mit41 4.43 VS 1.74 38 ± 0.6 (72)
a 40 ± 0.4 (197)
b 40 ± 0.6 (103)
b
1 35.7
(33.7, 44.7)
D1Mit215 3.52 S 4.15 37 ± 0.6 (92)
a 40 ± 0.4 (180)
b 41 ± 0.6 (101)
b
Fat pad weight (g)
IG 1 41.7
(33.7, 44.7)
D1Mit215 5.38 VS 5.88 0.79 ± 0.05 (92)
a 1.02 ± 0.04 (179)
b 1.12 ± 0.05 (101)
b
ED 1 39
(33.7, 44.7)
D1Mit215 6.20 VS 7.02 1.15 ± 0.06 (92)
a 1.43 ± 0.05 (179)
b 1.61 ± 0.06 (101)
c
MS 1 41.7
(33.7, 44.7)
D1Mit215 4.14 S 4.78 0.32 ± 0.02 (92)
a 0.42 ± 0.02 (179)
b 0.43 ± 0.02 (101)
b
RP 1 39
(33.7, 44.7)
D1Mit215 4.62 VS 5.40 0.33 ± 0.02 (91)
a 0.44 ± 0.02 (179)
b 0.47 ± 0.02 (101)
b
SC 1 39
(33.7, 44.7)
D1Mit215 6.39 VS 7.24 0.37 ± 0.03 (92)
a 0.54 ± 0.03 (179)
b 0.56 ± 0.03 (101)
b
Sum 1 40.7
(33.7, 44.7)
D1Mit215 6.26 VS 7.01 2.9 ± 0.16 (92)
a 3.8 ± 0.13 (179)
b 4.2 ± 0.18 (101)
b
Carcass weight (g)
11 40
(32, 43)
D11Mit41 4.48 VS 1.88 32 ± 0.4 (72)
a 34 ± 0.3 (197)
b 34 ± 0.4 (102)
b
14 72.5
(65.5, 76.1)
D14Mit107 3.67 S 4.53 34 ± 0.5 (81)
a 34 ± 0.3 (193)
a 32 ± 0.4 (96)
b
Phenotypic data are presented as mean ± sem. Means labeled with different letters are significantly different from one another (P < 0.05). Chr, chromosome; CI,
2 LOD support interval; %, total variance explained by R-square; IG, inguinal; ED, epididymal; MS, mesenteric; RP, retroperitoneal including perirenal; SC,
subscapular; Sum, sum of the 5 fat pads above; GW Sig., genome-wide significance; S, significant; VS, very significant.
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Page 5 of 17Figure 2 Plot of one-dimensional genome-wide scans for (B6 × TH) F2 male progeny on 19 autosomes. The associated phenotypic traits
are plasma triglyceride and cholesterol levels as indicated. The lod score is plotted as a function of genome location. The horizontal lines
represent critical values at the 99% (P < 0.01), 95% (P < 0.05) and 90% (P < 0.1) significance levels.
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Page 6 of 17Figure 3 Plot of one-dimensional genome-wide scans for (B6 × TH) F2 male progeny on 19 autosomes. The associated phenotypic traits
are plasma glucose levels and body, fat pad and carcass weights as indicated. The lod score is plotted as a function of genome location. The
horizontal lines represent critical values at the 99% (P < 0.01), 95% (P < 0.05) and 90% (P < 0.1) significance levels.
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Page 7 of 17mice that were homozygous for the B6 alleles at the
D19Mit30 locus exhibited a significantly lower plasma
glucose level when they were homozygous either for the
TH allele at the D15Mit2 locus or for the B6 allele at
the D12Mit233 l o c u sa sc o m p a r e dw i t ho t h e rp o s s i b l e
genotype combinations at the loci (Figure 4A and 4B).
Similarly, mice that were homozygous for the B6 allele
at the D14Mit107 locus on Chr 14 had a significantly
lower plasma triglyceride level if they were homozygous
for the TH alleles at the D7Mit109 locus on Chr 7 (20
weeks of age) (Figure 4C).
Candidate genes using genetical genomics in the F2 mice
In order to seek candidate genes underlying the QTLs,
we applied a genetical genomics approach using a subset
of the F2 mice (n = 16) with differential hypertriglyceri-
demia, but not overtly diabetic. We analyzed gene
expression levels in four critical tissues associated with
diabetes, including liver, adipose tissue, skeletal muscle,
and pancreas. ANOVA was used to identify associations
between markers and gene expression in each tissue. In
total, 8764 gene expression traits in liver, 1410 in adi-
pose tissue, 1832 in skeletal muscle, and 4130 in pan-
creas exhibited an association with the markers tested.
Among these, we searched for gene expression traits
that were associated with the markers linked to physio-
logical traits to select candidate genes for the QTLs
(Table 4). When cis-acting transcript is defined as a
locus residing within 20 cM of the gene location [10],
this analysis revealed 4 putative cis-acting transcripts;
coiled-coil domain containing 46 (Ccdc46)g e n ei nl i v e r
for the hypertriglyceridemia QTL near D11Mit132,
signal-regulatory protein beta 1 (Sirpb1) gene in adipose
tissue for the hypercholesterolemia QTL near
D3Mit304, RIKEN cDNA 1700009P17 (1700009P17Rik)
gene in liver for the hypercholesterolemia QTL near
D1Mit113, and chymotrypsin C (caldecrin) (Ctrc)g e n e
in pancreas for the diabetes QTL near D4Mit312. These
4 genes have mostly unknown association with lipid and
glucose metabolism or obesity.
As another method to select possible candidate genes,
we searched for gene expression corresponding to genes
located near the QTLs that were correlated with physio-
logical traits [11]. Gene expression levels of many genes
in adipose tissue were correlated (P < 0.05) with body
weights and/or fat pad weights (Table 5). Notable ones
included insulin receptor substrate 1 (Irs1)g e n ea n d
monoacylglycerol O-acyltrasferase 1 (Mogat1)g e n e
located within the Chr 1 obesity QTL interval near
D1Mit215. Within the Chr 1 QTL interval, insulin-like
growth factor binding protein 2 (Igfbp2) gene expression
levels in liver were also negatively correlated with
mesenteric fat pad weights. Interestingly, we also
observed increased gene expression levels of multiple
chemokine (C-C motif) ligands, including Ccl9, Ccl6,
and Ccl3 in adipose tissue, being positively correlated
with body and fat pad weights. These genes all map on
the Chr 11 body weight QTL interval near D11Mit41.
Table 3 Summary of all QTL pairs detected using pair-wise scans in the F2 mice
QTL 1 QTL 2 LOD %
Trait Chr Best location
(cM)
Closest marker
to peak LOD
Chr Best location
(cM)
Closest marker
to peak LOD
Full Add Int
Glu 12 wk 15 53.7 D15Mit2 19 27 D19Mit30 10.4 3.6 6.8 8.5
53 6 D5Mit80 7 28.7 D7Mit231 9.3 2.9 6.4 6.5
12 53 D12Mit233 19 28 D19Mit30 9.3 2.8 6.5 5.8
Tg 16 wk 3 21.6 D3Mit304 13 38 D13Mit26 12.3 2.1 10.2 4.8
Tg 20 wk 7 79.7 D7Mit109 14 59.5 D14Mit102 11.7 1.3 10.4 4.8
10 24 D10Mit130 17 75 D17Mit123 10.8 2.8 8.1 5.0
59 9 D5Mit101 16 51.3 D16Mit152 11.1 0.9 10.2 3.1
Chol 8 wk 5 33 D5Mit80 17 30 D17Mit54 12.9 2.1 10.8 4.8
5 107 D5Mit101 14 57.5 D14Mit107 9.3 1.9 7.4 4.0
Chol 24 wk 1 68.7 D1Mit26 10 50 D10Mit11 13.4 5.8 7.6 7.5
15 45.7 D5Mit2 16 57.3 D16Mit152 10.5 2.0 8.6 4.2
4 14.3 D4Mit97 59 8 D5Mit101 13.6 1.8 11.8 3.7
IG FPW 7 82.7 D7Mit109 85 2 D8Mit242 9.9 3.0 6.9 3.7
Sum FPW 7 71.7 D7Mit109 17 76 D17Mit123 9.8 2.7 7.1 3.9
Chr, chromosome; Full, the Lod score for the full model (including additive effects and interaction); Add, the Lod score for two locus additive effects; Int, the Lod
score for the interaction (Full - Add); %, total variance explained by R-square; Glu, glucose; Tg, trighlyceride; Chol, cholesterol; IG FPW, inguinal fat pad weight;
Sum FPW, sum of the 5 regional fat pad weights; wk, week.
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Page 8 of 17Real-time quantitative RT-PCR (qRT-PCR)
We conducted qRT-PCR analysis for candidate genes
obtained from the microarray data or literature search
(Table 6). Gene expression levels of Ccdc46 in liver, Ctrc
in pancreas, and Sirpb1 in adipose tissue were significantly
up-regulated in TH mice compared with B6 mice. On the
other hand, the level of gene expression of 1700009P17Rik
was significantly down-regulated in liver from TH mice
compared with B6 mice. The gene expression levels of
Irs1, Mogat1,a n dIgfbp2 were significantly down-regulated
in adipose tissue from TH mice compared with B6 mice.
Apolipoprotein A-II (Apoa2) gene in dyslipidemia in TH
mice
Apoa2 gene maps to the distal region of mouse Chr 1,
near the Chr 1 QTL linked to hypercholesterolemia and
hypertriglyceridemia in the F2 mice. Through transgenic
and knockout studies it has been shown that Apoa2 is
involved in controlling plasma cholesterol and triglycer-
ide levels and over-expression causes insulin resistance
and obesity [12-14]. In order to test if Apoa2 could be
the Chr 1 hyperlipidemia QTL, we conducted sequence
comparison of the coding region between TH and B6
mice. There were 7 nucleotide substitutions in the
Apoa2 coding sequence, resulting in 3 amino acid differ-
ences in the two strains (Figure 5). The gene expression
level of Apoa2 was not significantly different between
TH and B6 mice in liver (Table 6).
Discussion
Through genome-wide linkage scans using an F2 inter-
cross population from TH and B6 strains, we identified
multiple QTLs and interacting loci linked to hyperlipi-
demia, hyperglycemia, and obesity phenotypes. Further,
genetic study of gene expression in a subset of this F2
population led to potential candidate genes for the
QTLs.
Some limitations of this study need to be recognized.
First, marker spacing in this study was approximately
20-cM, which was at the lower end of the generally
accepted marker density (10 - 25 cM) for QTL genome
scans [15] and could cause underestimation of the num-
ber of QTLs identified in this study. However, it has
been shown that the power of detecting a QTL is barely
influenced by marker spacing in the range of 10 to 20
cM, with most (over 70%) of the power retained even at
50 cM spacing [16]. Therefore, it is unlikely that there
are QTLs with stronger effect than were identified in
our F2 cross. Fine mapping studies to further define the
QTLs identified will provide further validation. Second,
measurements of plasma glucose, lipid and insulin levels
are sensitive to multiple environmental perturbations,
such as animal husbandry, testing procedures, and
environmental conditions. This creates phenotypic
(A)
(B)
(C)
Figure 4 Two locus interactive effects in (B6 × TH) F2 male
progeny. The associated phenotypic traits are hyperglycemia (A
and B) and hypertriglyceridemia (C). Lines connect means ± SEM of
the plasma glucose or triglyceride levels for one marker on the X
axis as homozygous for B6 (B), heterozygous for TH and B6 (H) or
homozygous for TH (T) associated with another marker
homozygous for B6 (B, solid line), heterozygous for B6 and TH (H,
dotted line) or homozygous for TH (T, dashed line).
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Page 9 of 17Table 4 Gene expression associated with physiological trait QTL markers in the subset of F2 mice (n = 16)
Marker Tissue Gene
D1Mit113 Adipose
tissue
Abcb9, Dub2a, Myo1a, 4930571K23Rik, Pnma2, Tcea2, Fahd2a, Zmiz1, Actr1b, Rab3 d, Zscan2, Myo10, Arhgap8, Mrgpra2,
4933431C10Rik, Oprm1
Liver Clasp1, 1700009P17Rik, 9130009M17Rik, Wdr40b, Rasal2, Gabra3, Mrgpre, Lsm2, 2610039C10Rik, Zfp354b
Muscle A630033E08Rik, Pcdhgc4, Kbtbd3, Tbc1d23, Tmem181
Pancreas Snca, Lrch1, Plcl1, Lpin2, 2410005O16Rik, Abcb9, Rpp30, Sepw1
D11Mit132 Adipose
tissue
Rab33a, Homer1, Cntfr, 2310068J16Rik, 4930427A07Rik
Liver Diablo, Snx29, Galnt3, H13, Dqx1, 4930563E22Rik, 4931429I11Rik, Tmem129, Rasgrp1, 4930452B06Rik, 4930528G23Rik,
4933413J09Rik, Ccdc46, Zfp61, Ypel2, Hs3st3a1, 4933404O12Rik, Lgi3, Cplx2, Pif1, Fkrp, 9530010C24Rik, Rasa4, Rlbp1, Hoxa10,
Lysmd2, Mipol1, Hps1, Csl, Fgf18, Mcpt9, Rnf151, Ggt7, Sema6c, 4921511C04Rik, Med13l, 4930432H15Rik, A330021E22Rik, Vwc2,
Nfasc, Zic4, Htt, A230001M10Rik, Zic2, Cnnm4, Eif4e2, Tbx19, Kcnab3, Napg
Muscle Tmem144, Dsc3, Tm9sf1, Fancb, Eif3 d, Gtf2e2, Tph1, 2900022B07Rik, 2010004M13Rik, Mgat3
Pancreas Ednrb, Epn2, Rnf214, Spata17, 2310047O13Rik, Dnajb4, 4930455H04Rik, Emp2, Cds2, Slc2a13, Cybb, 3110052M02Rik,
4933403F05Rik, Skiv2l2, Klhl13, Myo1b, Supt16 h, Usp9x, Crot, Ogt, P4ha1, Igf1r, Akt1s1, Rabepk, Ptprj, Pml, Chd1, Tspan8,
6430531B16Rik, 4933411K20Rik, Tpst1, Bnip2, Map4k4, Nup50, Fzd8, Olfml2b, Anapc4, Car8, Eif3s10
D4Mit178 Adipose
tissue
Trpv4, Azgp1, Klf1, B3galt6, Cgref1, Ptprk, 1110033F14Rik, Gpm6b
Liver Tcfe2a, Wipi1, Lyrm2, Nudt16l1, Ttf2, Gngt2, 9430051O21Rik, Cd86, Rad23b, Tmem175, Pola1, Ankrd49
Pancreas Lmbr1, 4932415G12Rik, Clock, Itm2a, Tcf25
D8Mit242 Adipose
tissue
Adrb3, Isca1, Cep55, Ppp1r9a
Liver 6530406A20Rik, Lsm6
D3Mit304 Adipose
tissue
Rhod, Akt3, Dnmt3a, Grhl1, Dppa3, Rpl7, Krt20, Tm7sf4, Palb2, Hk3, Dusp16, Acad9, Pctk3, Cxcl2, Fabp7, Top3b, Slamf6, Sirpb1
Liver Exosc9, Kcne3, Acad9, 2610202C22Rik, Dmc1, Mapk8
Muscle Os9, Coro1c, Gna-rs1, 4921508A21Rik, 5830420C07Rik, H2-T18
Pancreas 4632419K20Rik, Rbbp8, Foxk2, Ccdc7, Stag1, Uba1, Rcor3, Cryl1, Vmn2r29, 2610028H24Rik, Dag1, Itga5
D4Mit312 Adipose
tissue
Gjb3, Tnni2, Tnnc2, Ckm, Pvalb, Lamb3, Slc39a3, Mmp3, Atp2a1, 1110008J03Rik, Mark1, Hipk1, Ptcra, Tcap, Mfap4,
2510006D16Rik, C430004E15Rik, Myh4, Ttn, 9030625N01Rik, A930012M21Rik, 2900011L18Rik, Fntb, Dhx29, Mylpf, Tnnt3, Sphk1,
2410127E18Rik, 3110082I17Rik, Marveld3, 9930104L06Rik, Plekhg4, Flnb, Lpin2
Liver Vmn2r88, Egr2, Ftsj1, 1810059H22Rik, Frmd5, Gng2, Asxl2, P4ha3, Fpr1, Zfp54, 4921515E04Rik, Rab36, Pou2f1, Syt7,
4930552P12Rik, Klk1b1, Map3k4, Pip5k1b, Rims2
Muscle Rbm26, Efcab4a, Edg5, Jam2, Ptpn14, OTTMUSG, Hif1a, Cdca7l, Ep400, 1110034A24Rik, Bet1l, Ick, Bcl9, Shc4, Adam12, Col9a1
Pancreas Gnb1, Pdcd6ip, Stub1, Ctrc, Alkbh5, Xpnpep3, Slc25a29, Zswim5, H13, 4930534B04Rik, Ascc2, St3gal6, Rock2, Dnm3os, Bet1l, Lox,
Gjb4, Xpc
D11Mit41 Adipose
tissue
Ptpn11
Liver Dusp3
Muscle Exoc7, Plekhg1
Pancreas Pja2
D1Mit215 Adipose
tissue
Isl1, Plekhf2, Baalc, Dusp18, Lim2, A130004G07Rik, Vstm2l
Liver Rnd3, Slc7a4, Jarid1b, Clasp1, 1700009P17Rik, Casp3, D730045B01Rik, Foxp4, Nono, 5830411G16Rik, 6030458A19Rik, Dok7,
Centb1, Ddef2, 5830418K08Rik, Tmem179, Cux1, 1110001A07Rik, Sp6, Zfp560, Pnmal1, Npb, 7420416P09Rik, Vta1, Crybb1,
9930031P18Rik, Tmem202, 4932409I22Rik, Nav2, Bhlhb8, Skiv2l2, Zfp383, Cxcl9, Akr7a5, Ttc3, Itga3, Gpatch2, Ash2l, Dub2a, Gypa,
2210407C18Rik
Muscle 2810454L23Rik, Ugcgl2, 4930558K02Rik, Cercam, Fbxo10, Rbms3, C130039O16Rik, D130051D11Rik, Ifnar2, Smchd1, Edg6, Fgd5,
Sertad3, Mcm4
Pancreas Sept8, Bloc1s3, Mchr1, Mfhas1, Prpf40a, Morc2a, Slc40a1, Haghl, Grb10, 8430437O03Rik, 2210404J11Rik, Fndc4, Hsd17b4, Sf3b2,
Alkbh1, Zfp652, Plcxd2, B430119L13Rik, Pdzk1ip1, Epha10, Spnb2, Lrch1, 9930031P18Rik, Mfap5, Det1, Fcrls, Myh11, Ifna5, Gpx6,
Zhx3, 4930503L19Rik, Ascc3l1, Gli3, Tubb5, Pex10, Snf1lk, Cog1, Gm693, Pogz, Dbil5, Capn9, Itm2a, Ttc3, Zfp282, Cldn23, Clec4a2,
Eif3s10
D14Mit107 Adipose
tissue
Spg11
Liver Hbb-b1, Gpr146, Hba-a1
Muscle Shq1
Genes in bold are putative cis-acting transcripts.
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Page 10 of 17Table 5 Correlations of the gene expression levels with physiological traits
Tissue Positively
correlated
Negatively
correlated
Trait
Near D1Mit113
Adipose
tissue
Prrx1, Creg1, Nuf2, Sh2d1b1, Fcgr4, Fcgr3, Fcer1g, Adamts4, Cd84,
Pea15a, Atp1a4, Slamf9, Tagln2, Vsig8, Slamf8, Wdr26, Degs1,
Kctd3, Atf3
Gas5, Opn3, Sdccag8, Hnrnpu, Trp53bp2, Iars2, Ptpn14 BW
FPW
Muscle Sft2d2, Dedd, Sdhc
Mrps14, Prrx1, Nme7, Mpzl1, Cd247, Lrrc52, Fcrla,
Adamts4, Pvrl4, Cd244, Slamf7, Igsf9, Tagln2
Chol
Tg
Near D11Mit132
Adipose
tissue
Ccl6, Rab5c, Atp6v0a1, Psmc3ip, Tubg1, Psme3, Dusp3, Grn, Nmt1,
Plekhm1, Cdc27, Mrc2, Tanc2, Wipi1, Kpna2
Stat5b, Rdm1, Rprml, Helz BW
FPW
Muscle Prkar1a, Sgca, Spop, Krtap3-1 Fkbp10, Acly, Stat3, Vps25, Cntd1, Psme3, Ifi35, Brca1, Slc25a39,
Gpatch8, Gm1564, Eftud2, Hexim2, Lyzl6, Wnt3, Crhr1, Arsg, Slfn10,
Slfn3, Kal1, Lhx1, Ggnbp2, Usp32, Ptrh2, Dhx40, Rad51c, Msi2,
Car10, Mbtd1, Mycbpap, Rsad1, Hils1, Zfp652, Ube2z, Calcoco2,
Skap1, Scrn2, Kpnb1, Pip4k2b, Med1, Crkrs, Gsdma2, Wipf2, Krt12
Tg
Near D4Mit178
Adipose
tissue
Col15a1, Nipsnap3a, Svep1, Slc31a1, Orm1, Tnc, Megf9, Mpdz Rgs3, Orm3 BW
FPW
Muscle Mup4, Mup3, Zfp37, Orm2, Pappa, Dbc1, Cdk5rap2, Rasef Tg
Near D8Mit242
Adipose
tissue
Tmem208, Lypla3, Cyb5b, Hp, Mlkl, Cenpn, Gcsh, Cotl1, Gins2 Cirh1a, Ces3, Bbs2, Terf2ip, Fbxo31 BW
FPW
Muscle Cog8, Znrf1, Gse1 Cdh8, Cklf, Cmtm2a, Ccdc79, Lcat, Prmt7, Sntb2, Adat1, Terf2ip,
Mon1b, Jph3, Cdt1, Zfp319, Gins3, Setd6
Tg
Near D3Mit304
Muscle Agtr1b, Tbl1xr1, Arpm1, Samd7, Cldn11, Slc7a14, Pik3ca, Ccdc39,
Sox2
Tg
Adipose
tissue
Fabp5, Sirpb1, Aadacl1, Tpd52 Lrrcc1, Car3, Mynn, Phc3, Zfhx4 BW
FPW
Near D4Mit312
Muscle Nadk Eif4g3, Ubxd3, Pax7, Arhgef19, Tnfrsf8, Rex2, Clcn6, Fbxo6, Gpr153,
Morn1, Gabrd, Ssu72, Ttll10, Dhdds, Lin28, Sepn1, Srrm1, Rcan3,
Cnr2, Htr1 d, Ephb2, Ptafr, Eya3
Tg
Adipose
tissue
Efhd2, Lzic, Pgd, Plod1, Dnajc16, Necap2, Mfap2, Atp13a2, Igsf21,
Capzb, Pla2g2e, Hspg2, C1qc, Ephb2, Clic4, Ldlrap1, Paqr7, Stmn1
Sdf4, Thap3, Per3, Park7, H6pd, Tmem201, Tardbp, Gale, Srrm1, Syf2,
Tmem57
BW
FPW
Near D11Mit41
Adipose
tissue
Eif4a1, Atp6v0a1, Psmc3ip, Dusp3, Nmt1, Mpdu1, Cd68, Garnl4,
Serpinf1, Slc43a2, Pitpna, Blmh, Pigs, Evi2a, Rhbdl3, Ccl2, Ccl7, Ccl9,
Ccl6, Ccl3, Dynll2, Mmd, Lrrc59, Col1a1, Top2a
Rdm1, Ssh2, Unc45b, Acaca, Ggnbp2, Med13, Vezf1,
Tmem100, Spop, Kpnb1, Erbb2, Thra,
BW
FPW
Muscle Sgca, Spop, Krtap3-1 Fkbp10, Acly, Cntd1, Ifi35, Lyzl6, Aurkb, Trp53, Alox12, Itgae, Phf12,
Nek8, Spag5, Nos2, Rhot1, Zfp207, Fndc8, Slfn10, Slfn3, Kal1, Lhx1,
Ggnbp2, Usp32, Ptrh2, Dhx40, Rad51c, Msi2, Car10, Mbtd1,
Mycbpap, Rsad1, Hils1, Zfp652, Ube2z, Calcoco2, Skap1, Scrn2,
Kpnb1, Pip4k2b, Crkrs, Gsdma2, Wipf2, Krt12
Tg
Near D1Mit215
Adipose
tissue
Slc11a1, Col6a3 Ikzf2, Usp37, Cyp27a1, Mogat1, Irs1 BW
FPW
Liver Igfbp2 FPW
Muscle Sumo1, Spag16, Tnp1, Vil1, Plcd4, Zfp142, Ttll4, Cyp27a1, Des,
Epha4, Pax3, Mrpl44, Cops7b, Chrng
Tg
Near D14Mit107
Adipose
tissue
Dock9 BW
FPW
Muscle Dock9, Dzip1, Oxgr1, Ipo5, Farp1, Fgf14,T g
Genes located in physiological trait QTL intervals, showing correlations of the gene expression levels with physiological traits (P < 0.05) are detected by
microarray and regression analyses using the subset of F2 mice (n = 16). Genes in bold are confirmed by qRT-PCR. BW, body weight; FPW, fat pad weight; Chol,
cholesterol; Tg, triglyceride.
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Page 11 of 17variation that may result in less power to detect the
genetic determinants for physiological differences or
inconsistency in detected QTLs across time. This may
have caused the observed fluctuations in QTL locations
over time. The third potential limitation was running
microarray analysis on a small subset of F2 mice
selected from the upper and lower tails of the frequency
distribution of the plasma triglyceride levels without
severe hyperglycemia. Populations with phenotypic
extremes are known to be most genetically informative
as genes influencing to the disease should be concen-
trated in the extremes of the populations. Thus, even
with small number of mice, our data from multiple tis-
sues did identify potential novel candidate genes that
may be involved in pathogenic mechanisms in TH mice.
In mice, Apoa2
b allele, characterized by Ala61-to-
Val61 substitution, has been reported to be hyper-
morphic in increasing plasma cholesterol levels and
appears in multiple mouse strains [17,18]. The same
polymorphism of Apoa2 gene was revealed in TH strain,
suggesting Apoa2 as the candidate gene underlying the
Chr 1 QTL linked to hypercholesterolemia. Indeed,
many cholesterol QTLs were previously detected in the
Apoa2 region in separate genetic crosses of mice and
Apoa2 was suggested as a likely candidate across the
strains [19]. Functional studies related to Apoa2
b allele
in TH mice are warranted.
Unlike cholesterol, age-specific genetic loci were found
for plasma triglyceride levels, suggesting that different
genetic mechanisms are responsible for the onset versus
progression of hypertriglyceridemia in TH mice. It is
noteworthy that the Chr 1 locus linked to hypertrigly-
ceridemia at 8 weeks of age overlapped the Chr 1
hypercholesterolemia QTL. It might be speculated that
the onset of both hypertriglyceridemia and hypercholes-
terolemia shares the same genetic factors, but distinct
genetic mechanisms are involved in the progression of
the disease in TH mice. This age-related genetic effect
has been previously recognized and appreciated in com-
plex traits including diabetes and obesity [20,21]. Data
Table 6 Real-time quantitative RT-PCR for selected genes in B6 and TH mice (males, 16 week, n = 5 each group)
Gene symbol Gene name Chr Near marker Trait Tissue Fold P
1700009P17Rik RIKEN cDNA 1700009P17 gene 1 D1Mit113 Tg
Chol
Liver 0.2 0.0007
Ccdc46 Coiled-coil domain containing 46 11 D11Mit132 Tg Liver 7 0.0019
Sirpb1a Signal-regulatory protein beta 1A 3 D3Mit304 Chol Adipose tissue 2.6 0.02
Ctrc Chymotrypsin C (caldecrin) 4 D4Mit312 Glu Pancreas 17 <0.0001
Igfbp2 Insulin-like growth factor binding protein 2 1 D1Mit215 FPW Liver 0.50 0.05
Adipose tissue 0.1 <0.0001
Cyp27a1 Cytochrome P450, family 27, subfamily a, polypeptide 1 1 D1Mit215 BW
FPW
Adipose tissue 1.2 0.10
Irs1 Insulin receptor substrate 1 1 D1Mit215 BW
FPW
Adipose tissue 0.6 0.05
Mogat1 Monoacylglycerol O-acyltransferase 1 1 D1Mit215 FPW Adipose tissue 0.2 0.0002
Usp37 Ubiquitin specific peptidase 37 1 D1Mit215 BW
FPW
Adipose tissue 1.0 0.90
Spag5 Sperm associated antigen 5 11 D11Mit41 Tg Muscle 1.02 0.95
Ccl9 Chemokine (C-C motif) ligand 9 11 D11Mit41 BW
FPW
Adipose tissue 2.2 0.01
Ccl6 Chemokine (C-C motif) ligand 6 11 D11Mit41 BW
FPW
Adipose tissue 1.4 0.20
Ccl3 Chemokine (C-C motif) ligand 3 11 D11Mit41 BW
FPW
Adipose tissue 5.5 <0.0001
Msi2 Musashi homolog 2 (Drosophila) 11 D11Mit41 Tg Muscle 1.03 0.75
Agtr1b Angiotensin II receptor, type 1b 3 D3Mit304 Tg Muscle 1.11 0.85
Pik3ca Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide 3 D3Mit304 Tg Muscle 0.91 0.24
Ccdc39 Coiled-coil domain containing 39 3 D3Mit304 Tg Muscle 0.66 0.40
Ccdc79 Coiled-coil domain containing 79 8 D8Mit242 Tg Muscle 0.59 0.40
Apoa2 Apolipoprotein A-II 1 D1Mit113 Tg
Chol
Liver 1.07 0.08
Insig2 Insulin induced gene 2 1 D1Mit113 Tg
Chol
Muscle 0.95 0.73
Zfp69 Zinc finger protein 69 4 D4Mit312 Glu Adipose tissue 2.2 0.03
Chr, chromosome; Fold, the fold change in TH vs. B6 (TH/B6); Tg, triglyceride; Chol, cholesterol; Glu, glucose; FPW, fat pad weight; BW, body weight.
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Page 12 of 17collection at multiple time points provides power to
detect age-dependent effects that can be easily missed
with a single time point study.
The Chr 11 and Chr 4 hypertriglyceridemia QTLs
map near the loci previously observed for atherosclerosis
in mice; Ath19 on Chr 11 [22,23] and Ath8 on Chr 4
[22,24]. The authors proposed the angiopoeitin-like pro-
tein 3 (Angptl3) gene, containing a coiled-coil domain,
as a positional candidate gene for the Ath8 [24]. Inter-
estingly, Angptl3-null mice show markedly low plasma
triglyceride concentrations [25]. The Chr 8 hypertrigly-
ceridemia QTL maps to the region of Tgl1 linked to
serum triglyceride levels in KK/Ta × (BALB/c × KK/Ta)
F1 backcross mice [26].
A major QTL for the hyperglycemic (diabetic) trait
was identified on the distal region of Chr 4. Previously,
several QTLs for diabetes and diabetes-related pheno-
types have been mapped in this region in independent
cohorts of mice and rats [27]. Among those, QTLs
directly linked to plasma glucose levels included Nidd1
in F2 mice from NZO × NON, a locus near D4Mit203
in F2 mice from C57BL/KsJ × DBA/2, and Nidd/SJL in
backcross mice from (NZO × SJL) × NZO.
Recently, the zinc finger protein 69 (Zfp69)g e n ew a s
identified as a candidate for the diabetes QTL of Nidd/
SJL [28]. An allelic variation of Zfp69 was observed in
multiple inbred strains; allele carried by B6 and NZO
strains causing truncated mRNA was associated with
reduced diabetes susceptibility, while allele carried by
SJL and NON strains producing normal mRNA was dia-
betogenic [28]. It is possible that the TH strain, which is
close to Swiss family strains http://jaxmice.jax.org/
strain/005314.html, may carry the SJL allele of Zfp69.
This notion is possibly supported by the observed higher
gene expression of Zfp69 in TH mice compared to B6
mice (Table 6).
Body weight is a compound trait reflecting the weights
of lean muscle and bones as well as fat mass. A QTL
near D11Mit41 on Chr 11 was very significantly linked
to body weight (Table 2). This locus was also associated
with carcass weight, suggesting its major effect on lean
mass. Among multiple body weight-related QTLs
mapped to this Chr 11 interval [29], the Wg4 (also
known as Q11Ucd1) locus behaves similarly to the Chr
11 body weight QTL, affecting growth rate and carcass
lean mass in hg/hg F2 population from a cross of B6-hg/
hg x CAST/EiJ [30].
A major QTL near D1Mit215 on Chr 1 was linked to
all the fat pad weights and body weights at 24 weeks of
age. This chromosomal interval contains Nob3,s i g n i f i -
cantly linked to adiposity (defined as body weight and
body fat) in F2 progeny from NZO and B6 mice [31].
Several other QTLs associated with body weights were
identified in this interval in mice, namely W3q12 and
W10q6 [32] and Bwtq1 [33]. The human orthologous
region of the Chr 1 QTL is 2q33-37. Based on known
Figure 5 Apoa2 cDNA sequence comparison in TH and B6 strains.
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Page 13 of 17functional relationship to metabolism, a few genes
mapped in this region, including Irs1, Mogat1 and
Igfbp2, are considered as candidates.
Obesity has been known to be a low-grade chronic
inflammatory disease [34]. In this study, we observed
that the gene expression levels of multiple chemokines,
including Ccl9 and Ccl3, were significantly increased in
a d i p o s et i s s u eo fT Hm i c ec o m p a r e dt oB 6m i c e .T h e
gene expression levels of these genes were also positively
correlated with body and fat pad weights in the F2 mice
(Table 5).
Previous research found genetic determinants of dia-
betes and obesity in TH mice in backcross population
from F1(B6 × TH) × TH, including diabetes QTLs on
Chr 19 (Tanidd1)a n dC h r1 3( Tanidd2) and obesity
QTLs on Chr 7 (Tabw), Chr 4 (Tafat)a n dC h r6
(Tabw2) [5,35]. Two loci on Chr 18 and 16 interacted
with Tanidd1 and Tanidd2, respectively. These QTLs
w e r en o td e t e c t e di nt h ep r e s e n tF 2s t u d y .T h i sd i s c r e -
pancy is not totally surprising. As the detection of a
QTL is subject to the magnitude of phenotypic variation
within genotypes, QTL results in an F2 and a backcross
population from the same progenitors can be different
[36]. For example, when complete dominance exists for
the TH allele of a QTL, the power of a backcross [F1
(B6 × TH) × TH] for detecting this QTL is zero. Simi-
larly, QTL interaction effects could be affected by the
choice of an F2 or backcross, in part, due to the absence
of homozygous mice for B6 alleles in the backcross.
A n o t h e rs o u r c eo ft h ed i s c r e p a n c yi nr e s u l t sf r o mt h e
two studies could be the different physiological condi-
tions of the mice. Non-fasting plasma glucose levels
were measured in the backcross study, while 4-hour
fasting plasma glucose levels were used in the present
F2 study. Therefore, the present findings using F2 popu-
lation should be taken as additional genetic information
underlying the pathogenic mechanisms in TH mice, not
just an independent replication.
Conclusions
In summary, using ~380 male F2 mice from the B6 ×
TH intercross we detected 12 significant QTLs; 4 for
hypertriglyceridemia, 2 for hypercholesterolemia, 1 for
hyperglycemia, 2 for body weights, 1 for fat pad weights,
and 2 for carcass weights. Polymorphisms in Apoa2
gene are suggested to be responsible for the Chr 1 QTL
linked to hypercholesterolemia and hypertriglyceridemia.
Gene expression analysis added novel aspects and aided
the selection of candidates and biological mechanisms
for the QTLs. Future studies to define the molecular
bases of these QTLs will improve the understanding of
genetic contributions in diabetes related syndrome in
TH mice and ultimately in humans.
Methods
Animals
Mice were maintained on standard rodent chow with 4%
fat [Harlan Teklad Rodent Diet (W) 8604, Madison, WI]
ad libitum with free access to water (HCl acidified, pH
2.8-3.2) under controlled temperature and humidity
with a 12-hour light and dark cycle. All animal studies
were carried out with the approvals of The University of
T e n n e s s e eA n i m a lC a r ea n dU s eC o m m i t t e ea n dM a r -
shall University Animal Care and Use Committee. Mice
were euthanized by CO2 asphyxiation.
Genetic crosses
Male TH mice were mated to female B6 mice. The
resulting F1 hybrid mice were interbred to produce an F2
population. Male F2 mice were fasted for 4 hours at the
beginning of the light cycle (6:00-7:00 AM) and blood
was collected via the retro-orbital plexus using a hepari-
nized microcapillary tube at 8, 12, 16, 20, and 24 weeks
of age. Plasma was obtained by centrifugation (1,200 g)a t
4°C and plasma levels of glucose, true triglyceride, total
cholesterol, and insulin and body weights were measured.
A tt h ee n do ft h es t u d y ,m i c ew e r ek i l l e da n dt i s s u e s
including liver, skeletal muscle, pancreas, and adipose tis-
sue (inguinal, epididymal, mesenteric, retroperitoneal
including perirenal, and subscapular fat pads) were col-
lected, frozen in liquid nitrogen, and stored at -80°C for
RNA isolation. Respective fat pad weight and carcass
w e i g h t( b o d yw e i g h tw i t h o u tt h ef i v ef a tp a d s )w e r ea l s o
recorded during the dissection.
Plasma glucose, triglyceride, total cholesterol, and insulin
levels
Plasma levels of glucose (TR15103/1530-500, Thermo Elec-
tron, Louisville, CO), total cholesterol (TR13421, Thermo
Electron, Louisville, CO), and free and total glycerol (337,
Sigma, St. Louis, MO) were determined using commercial
colorimetric assays. Plasma true triglyceride concentrations
were estimated by subtraction of free glycerol from total
glycerol. Plasma insulin levels were determined using RIA
(RI-13K, Linco Research, St. Charles, MO).
Genotyping by PCR
Genomic DNA was extracted from tail tips using protei-
nase K [37] and two series of salt precipitation steps. The
DNA was PCR amplified using SSLP primers (Additional
file 1 Table S1) purchased (Invitrogen, Carlsbad, CA) or
synthesized (Sigma) based on sequences from Mouse
Genome Informatics http://www.informatics.jax.org/
javawi2/servlet/WIFetch?page=markerQF. The thermal
cycle consisted of 95°C for 2 min, followed by 49 cycles
of 94°C (20 sec), 50°C (30 sec) and 72°C (40 sec) and a
final extension at 72°C (7 min). Amplified products were
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FMC, Rockland, ME)/1% agarose (0710-500G, Amresco,
Solon, OH) gels in 0.5 × tris-borate-EDTA buffer, pH
7.4. The DNA was visualized by ethidium bromide (E-
1510, Sigma) staining.
RNA isolation
Total RNA was isolated from liver, muscle (combined
soleus and gastrocnemius), pancreas, and adipose tissue
(combined inguinal, epididymal, retroperitoneal, perire-
nal, and subscapular fat pads) using RNeasy Lipid Tissue
Midi Kit (75842, QIAGEN, Valencia, CA) according to
the manufacturer’s instructions. For adipose tissue, mus-
cle and pancreas, the entire tissue was homogenized and
total RNA extracted, whereas approximately 50% of the
liver was homogenized. Total RNA was further purified
using RNeasy MinElute Cleanup Kit (74204, QIAGEN)
for microarray analysis.
Microarray Analysis
Hybridizations were performed at the University of Ten-
nessee Affymetrix Facility (Knoxville, TN) using Affyme-
trix GeneChip® Mouse Genome 430 2.0 Array
(Affymetrix, Santa Clara, CA) following the standard pro-
tocol. The Mouse Genome 430 2.0 Array contains 45,000
probe sets on a single array to analyze the expression
level of over 39,000 transcripts and variants from over
34,000 well-characterized mouse genes (Affymetrix).
Total RNA isolated from adipose tissue, liver, muscle,
and pancreas of a subset of F2 mice (n = 16) were used
for microarray analysis, requiring 64 arrays. The 16 mice
were chosen from the upper and lower tails (8 each) for
plasma triglyceride distribution of all the male F2 mice,
excluding overtly diabetic mice. The phenotypic values of
these mice are presented in Table 1.
Real-time quantitative RT-PCR (qRT-PCR)
Total RNA was isolated from adipose tissue, liver, mus-
cle, and pancreas of B6 and TH male mice at 16 weeks
of age as described above. Total RNA (2 μg) was
reverse-transcribed with SUPERSCRIPT RT (11904-018,
Invitrogen) using oligo d(T)12-18 (18418-012, Invitro-
gen) as primer to synthesize first-strand cDNA in 20-μl
volume according to manufacturer’s instructions. The
primers used for the real-time PCR were proprietary for
Ctrc (PPM39932A), 1700009P17Rik (PPM27997A),
Sirpb1a (PPM39258A), Irs1 (PPM05117E), Cyp27a1
(PPM30124A), Mogat1 (PPM28787E), Usp37 (PPM6
0128A), Zfp69 (PPM40990E), Insig2 (PPM26980A),
Pik3ca (PPM05112A), Agtr1b (PPM31347B), Ccdc79
(PPM35025A), Ccdc39 (PPM28741A), and Apoa2
(PPM05347B) (SABiosciences, Frederick, MD). Oligonu-
cleotide primers were also synthesized (Sigma) using
sequences obtained from Primer Bank http://pga.mgh.
harvard.edu/primerbank for Ccdc46, Igfbp2, Ccl3, Ccl9,
Ccl6, Msi2,a n dSpag5 and from the published literature
for 36B4 [38] (Table 7).
The real-time PCR reaction was carried out in a 25-μl
volume in 1× SYBR Green PCR core reagents (PA-112,
SABiosciences) containing 1 μl cDNA template diluate
(1:5, v/v) and 6 pmol primers using ABI Prism 7700 or
7300 sequence detection system (Applied Biosystems,
Foster City, CA). For each sample, triplicate amplifica-
tions were performed and the average measurements
used for data analysis.
RT-PCR and sequencing of the Apoa2 gene
Total RNA was extracted from pancreas of B6 and TH
mice and the RNA (10 μg) was reverse-transcribed as
described above. The single-strand cDNA was diluted
with water (1:5, v/v), and 2 μl of the diluate was used to
amplify Apoa2 cDNA using the Expand Long Template
PCR System (Roche, Indianapolis, IN). Full length cod-
ing sequence was amplified using Apoa2 specific primers
F1 (5’-AGAATCGCAGCACTGTTCC-3’)a n dR 1( 5 ’-
GGAGAAAACAGGCAGAAGG-3’) derived from Mus
Musculus Apoa2 gene mRNA sequences (NM_013474).
PCR products were first electrophoresed on a 1.2 %
agarose gel. Bands of interest were excised from the gel,
and DNA fragments were isolated (K3051-2, Clontech,
Palo Alto, CA). The gel-purified PCR products were
directly sequenced with primers originally used to
Table 7 Primer sequences for real-time quantitative RT-PCR
Gene Forward Primer (5’ -3 ’) Reverse Primer (5’ -3 ’)
Ccdc46 GCTGAGACCGAGATGACTCTG GCACTTCGCACCTGATGAGA
Igfbp2 CAGACGCTACGCTGCTATCC CCCTCAGAGTGGTCGTCATCA
Ccl3 TTCTCTGTACCATGACACTCTGC CGTGGAATCTTCCGGCTGTAG
Ccl9 CCCTCTCCTTCCTCATTCTTACA AGTCTTGAAAGCCCATGTGAAA
Ccl6 GCTGGCCTCATACAAGAAATGG GCTTAGGCACCTCTGAACTCTC
Msi2 GACCTGTCGCCGATCTCTAC GCGCTTATGTAATTCCCCACTC
Spag5 ACAGTGAGTCTGAGTTCTGCC CTGTGAGTTTCTTGGTGAGTTCT
36B4 GAGGAATCAGATGAGGATATGGGA AAGCAGGCTGACTTGGTTGC
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automatically with fluorescent tags (3100 Genetic Analy-
zers, Applied Biosystems).
Statistical Analysis
QTL mapping
QTL analysis was run using R/QTL [39] with composite
interval mapping at default settings. Traits that showed
positive skew were log transformed. The estimated map
showed expansion compared to published marker loca-
tions, so the estimated map was used. This had the bene-
fit of resolving putative genotyping errors on Chr 4.
Genome wide significance thresholds were established by
identifying the 10th (suggestive), 5th (significant) and 1st
(very significant) percentiles from 10,000 permutations.
Microarray data analysis
Individual probe data were extracted using Bioconductor
http://www.bioconductor.org, and the gcRMA (robust
multi-array) process used to produce a signal measure
for each gene. Statistical analysis was performed using
SAS software (Cary, NC). A mixed ANOVA model [40]
was run on the normalized data, fitting genotype and tis-
sue treatment effects, and using array variation as the
experimental error. Genes with significant (P < 0.05)
ANOVA interaction, and significant pair-wise False Dis-
covery Rate [41] were considered differentially expressed.
Microarray expression data were also tested for relation-
ship to phenotypes using correlation analysis in SAS [11].
A total of 45,000 probes * 39 phenotypes = 1.75 million
regressions were run for each tissue. Similarly, analysis of
variance in SAS was conducted to identify associations
between markers and gene expression in each tissue,
comparing marker genotypes for differences in mean
expression at all microarray probes. P-values from both
analyses were protected at a 5% False Discovery Rate.
Microarray data have been submitted to the gene expres-
sion omnibus http://www.ncbi.nlm.nih.gov/geo/ under
the accession number GSE24637.
Real-time qRT-PCR data analysis
Triplicate threshold cycle times were averaged for each
mouse, and strain differences tested using a one-way
ANOVA in SAS software (Cary, NC), with the 36B4
control gene values as a covariate to avoid analysis of
ratios. Data are presented as relative fold-change using
B6 mice as the reference by 2
(ΔCt of TH mice - ΔCt of B6
mice) [42], where ΔCt represents the treatment mean
from ANOVA.
Physiological data analysis
Data analysis was conducted by ANOVA with StatView
5.0 (Abacus Concepts, Berkeley, CA). Differences were
considered significant at P < 0.05. All data are presented
as mean ± SEM.
Additional material
Additional file 1: Table S1 - Simple sequence length polymorphic
markers for the genome-wide scans of the (B6 × TH) F2 mice. The
file contains the list of genetic markers and their estimated genetic map
positions used in this study.
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